Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Trait mindfulness is associated with less amyloid, tau, and cognitive decline in individuals at risk for Alzheimer’s disease

View ORCID ProfileCherie Strikwerda-Brown, View ORCID ProfileHazal Ozlen, View ORCID ProfileAlexa Pichet Binette, View ORCID ProfileMarianne Chapleau, View ORCID ProfileNatalie L. Marchant, View ORCID ProfileJohn C. S. Breitner, View ORCID ProfileSylvia Villeneuve, for the PREVENT-AD Research Group
doi: https://doi.org/10.1101/2021.05.17.21257320
Cherie Strikwerda-Brown
1Douglas Mental Health University Institute, Centre for Studies on the Prevention of Alzheimer’s Disease (StoP-AD), Montreal, Quebec, Canada
2Department of Psychiatry, McGill University, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cherie Strikwerda-Brown
  • For correspondence: Sylvia.villeneuve@mcgill.ca
Hazal Ozlen
1Douglas Mental Health University Institute, Centre for Studies on the Prevention of Alzheimer’s Disease (StoP-AD), Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hazal Ozlen
Alexa Pichet Binette
1Douglas Mental Health University Institute, Centre for Studies on the Prevention of Alzheimer’s Disease (StoP-AD), Montreal, Quebec, Canada
2Department of Psychiatry, McGill University, Montreal, Quebec, Canada
3McGill Centre for Integrative Neuroscience, McGill University, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alexa Pichet Binette
Marianne Chapleau
1Douglas Mental Health University Institute, Centre for Studies on the Prevention of Alzheimer’s Disease (StoP-AD), Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marianne Chapleau
Natalie L. Marchant
4Division of Psychiatry, Faculty of Brain Sciences, University College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Natalie L. Marchant
John C. S. Breitner
1Douglas Mental Health University Institute, Centre for Studies on the Prevention of Alzheimer’s Disease (StoP-AD), Montreal, Quebec, Canada
2Department of Psychiatry, McGill University, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John C. S. Breitner
Sylvia Villeneuve
1Douglas Mental Health University Institute, Centre for Studies on the Prevention of Alzheimer’s Disease (StoP-AD), Montreal, Quebec, Canada
2Department of Psychiatry, McGill University, Montreal, Quebec, Canada
3McGill Centre for Integrative Neuroscience, McGill University, Montreal, Quebec, Canada
5Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada
6McConnell Brain Imaging Centre, Montreal Neurological Institute, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sylvia Villeneuve
  • For correspondence: Sylvia.villeneuve@mcgill.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

BACKGROUND AND OBJECTIVES Mindfulness, defined as non-judgmental awareness of the present moment, has been associated with an array of mental and physical health benefits, including improved cognitive functioning and changes to brain structure and function. Mindfulness may also represent a protective factor for Alzheimer’s disease (AD). Here, we tested the potential protective effect of trait mindfulness on cognitive decline and AD pathology in older adults at risk for AD dementia.

METHODS Two hundred sixty-one nondemented older adults with a family history of AD dementia were included from the PREVENT-AD observational cohort study, including 124 with Aβ- and tau-positron emission tomography (PET) scans. All participants completed measures of trait mindfulness and longitudinal cognitive assessments. Multivariate partial least squares analyses were used to examine relationships between combinations of different facets of trait mindfulness and (1) cognitive decline, (2) Aβ, and (3) tau.

RESULTS Higher levels of mindful nonjudgment, describing, and nonreactivity were associated with less cognitive decline in attention, global cognition, and immediate and delayed memory. Higher levels of mindful nonjudgment and nonreactivity were related to less Aβ-PET signal in bilateral medial and lateral temporoparietal and frontal regions. Higher levels of mindful acting with awareness, describing, nonjudgment, and nonreactivity were associated with less tau-PET signal in bilateral temporal regions, namely entorhinal cortex, amygdala, and parahippocampal, fusiform, and inferior temporal gyri. These relationships remained significant when additional demographic (age, sex, education and APOE status) and psychological (personality traits and neuropsychiatric symptoms) were included in analyses. When mindfulness, personality traits, and neuropsychiatric symptoms were entered into the same model, mindful nonjudgment showed the strongest association with cognitive decline and Aβ.

DISCUSSION Trait mindfulness is associated with less cognitive decline and less Aβ and tau in the brain in older adults at risk for AD dementia. In addition to its other health benefits, trait mindfulness may also represent a psychological protective factor for AD dementia. Longitudinal studies examining the temporal relationship between trait mindfulness and AD markers, along with mindfulness intervention studies with cognition and pathology as outcome variables, will be important for further clarifying the potential protective benefits of mindfulness on AD risk.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by a Canada Research Chair, a Canadian Institutes of Health Research Foundation Grant, a Canada Fund for InnovationGrant, and an Alzheimer's Association Grant (to SV). PREVENT-AD was launched in 2011 as a $13.5 million, 7-year public-private partnership using funds provided by McGill University, the Fonds de Recherche du Quebec-Sante, an unrestricted research grant from Pfizer Canada, the Levesque Foundation, the Douglas Hospital Research Centre and Foundation, the Government of Canada, and the Canada Fund for Innovation

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Institutional Review Board at McGill University

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Declarations of interest: None

Data Availability

Data will be released upon reasonable request

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted August 12, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Trait mindfulness is associated with less amyloid, tau, and cognitive decline in individuals at risk for Alzheimer’s disease
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Trait mindfulness is associated with less amyloid, tau, and cognitive decline in individuals at risk for Alzheimer’s disease
Cherie Strikwerda-Brown, Hazal Ozlen, Alexa Pichet Binette, Marianne Chapleau, Natalie L. Marchant, John C. S. Breitner, Sylvia Villeneuve, for the PREVENT-AD Research Group
medRxiv 2021.05.17.21257320; doi: https://doi.org/10.1101/2021.05.17.21257320
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Trait mindfulness is associated with less amyloid, tau, and cognitive decline in individuals at risk for Alzheimer’s disease
Cherie Strikwerda-Brown, Hazal Ozlen, Alexa Pichet Binette, Marianne Chapleau, Natalie L. Marchant, John C. S. Breitner, Sylvia Villeneuve, for the PREVENT-AD Research Group
medRxiv 2021.05.17.21257320; doi: https://doi.org/10.1101/2021.05.17.21257320

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Neurology
Subject Areas
All Articles
  • Addiction Medicine (243)
  • Allergy and Immunology (524)
  • Anesthesia (125)
  • Cardiovascular Medicine (1432)
  • Dentistry and Oral Medicine (219)
  • Dermatology (158)
  • Emergency Medicine (292)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (589)
  • Epidemiology (10326)
  • Forensic Medicine (6)
  • Gastroenterology (533)
  • Genetic and Genomic Medicine (2652)
  • Geriatric Medicine (255)
  • Health Economics (499)
  • Health Informatics (1744)
  • Health Policy (791)
  • Health Systems and Quality Improvement (680)
  • Hematology (269)
  • HIV/AIDS (570)
  • Infectious Diseases (except HIV/AIDS) (12117)
  • Intensive Care and Critical Care Medicine (650)
  • Medical Education (276)
  • Medical Ethics (83)
  • Nephrology (291)
  • Neurology (2479)
  • Nursing (145)
  • Nutrition (381)
  • Obstetrics and Gynecology (496)
  • Occupational and Environmental Health (569)
  • Oncology (1332)
  • Ophthalmology (403)
  • Orthopedics (152)
  • Otolaryngology (239)
  • Pain Medicine (172)
  • Palliative Medicine (51)
  • Pathology (344)
  • Pediatrics (785)
  • Pharmacology and Therapeutics (334)
  • Primary Care Research (296)
  • Psychiatry and Clinical Psychology (2417)
  • Public and Global Health (5029)
  • Radiology and Imaging (900)
  • Rehabilitation Medicine and Physical Therapy (533)
  • Respiratory Medicine (687)
  • Rheumatology (309)
  • Sexual and Reproductive Health (257)
  • Sports Medicine (246)
  • Surgery (300)
  • Toxicology (45)
  • Transplantation (141)
  • Urology (108)